{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:56:19Z","timestamp":1787860579133,"version":"build-2784847793"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s00228-005-0035-5","type":"journal-article","created":{"date-parts":[[2005,10,31]],"date-time":"2005-10-31T16:44:16Z","timestamp":1130777056000},"page":"763-768","source":"Crossref","is-referenced-by-count":75,"title":["Changes to methadone clearance during pregnancy"],"prefix":"10.1007","volume":"61","author":[{"given":"Kim","family":"Wolff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Boys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Rostami-Hodjegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Raistrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,11,1]]},"reference":[{"key":"35_CR1","volume-title":"Psychiatric Morbidity among adults living in private households, 2000. Office for National Statistics","author":"N Singleton","year":"2001","unstructured":"Singleton N, Bumpstead R, O\u2019Brien M, Lee A, Meltzer H (2001) Psychiatric Morbidity among adults living in private households, 2000. Office for National Statistics. The Stationary Office, London"},{"key":"35_CR2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1479-828X.1987.tb00952.x","volume":"27","author":"DA Ellwood","year":"1987","unstructured":"Ellwood DA, Sutherland P, Kent C, O'Connor M (1987) Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic. Aust & NZ Obsett and Gynae 27:92\u201398","journal-title":"Aust & NZ Obsett and Gynae"},{"key":"35_CR3","volume-title":"Research on the treatment of narcotic addiction: state of the art","author":"LP Finnegan","year":"1983","unstructured":"Finnegan LP (1983) Clinical perinatal and development effects of methadone. In: Cooper JR, Altman F, Brown BS, Czechowicz D (eds) Research on the Treatment of Narcotic Addiction: State of the Art. Maryland: National Institute on Drug Abuse, USA"},{"key":"35_CR4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/02791072.1991.10472236","volume":"23","author":"LP Finnegan","year":"1991","unstructured":"Finnegan L P (1991) Treatment issues for opioid-dependent women during the perinatal period. J Psycho Drugs 23:191\u2013201","journal-title":"J Psycho Drugs"},{"key":"35_CR5","first-page":"19","volume-title":"Drug abuse in pregnancy and neonatal effects","author":"LJ Salerno","year":"1979","unstructured":"Salerno LJ (1979) Prenatal care. In: Rementeria J (ed) Drug Abuse in Pregnancy and Neonatal Effects St Louis, CV, USA: Mosby Company pp.19\u201329"},{"key":"35_CR6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1479-828X.1989.tb01724.x","volume":"29","author":"W Giles","year":"1989","unstructured":"Giles W, Patterson T, Sanders F, Batey R, Thomas D, Collins J (1989) Outpatient methadone programme for pregnant heroin using women. Aust & NZ Obsett and Gynae 29:225\u2013229","journal-title":"Aust & NZ Obsett and Gynae"},{"key":"35_CR7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1037\/0033-2909.92.2.453","volume":"92","author":"J Householder","year":"1982","unstructured":"Householder J, Hatcher R, Burns W, Chasnoff I (1982) Infants born to narcotic-addicted mothers. Psych Bull 92:453\u2013468","journal-title":"Psych Bull"},{"key":"35_CR8","volume-title":"Drug dependence in pregnancy: clinical management of mother and child","author":"LP Finnegan","year":"1980","unstructured":"Finnegan LP (1980) (ed) Drug dependence in pregnancy: clinical management of mother and child. London: Castle House 1980"},{"key":"35_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1360-0443.2000.95223910.x","volume":"95","author":"G Fischer","year":"2000","unstructured":"Fischer G, Johnson RE, Eder H, Jagsch R, Peternell A, Weninger M, Langer M, Aschaver HN (2000) Treatment of opioid-dependent pregnant women with buprenorphine. Addiction 95:239\u2013244","journal-title":"Addiction"},{"key":"35_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10826088409057176","volume":"19","author":"F Suffet","year":"1984","unstructured":"Suffet F, Brotman RA (1984) Comprehensive care program for pregnant addicts: obstetrical, neonatal, and child development outcomes. Inter J of the Addict 19:199\u2013219","journal-title":"Inter J of the Addict"},{"key":"35_CR11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.1989.tb21017.x","volume":"562","author":"GS Wilson","year":"1989","unstructured":"Wilson GS (1989) Clinical studies of infants and children exposed prenatally to heroin. Ann NY Acad Sci 562:183\u2013194","journal-title":"Ann NY Acad Sci"},{"key":"35_CR12","first-page":"1","volume":"233","author":"SM Pond","year":"1985","unstructured":"Pond SM, Kreek MJ, Tong TG, Raghunath J, Benowitz NL (1985) Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exper Therap 233:1\u20136","journal-title":"J Pharmacol Exper Therap"},{"key":"35_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0740-5472(88)90004-9","volume":"5","author":"RL Mackie-Ramos","year":"1988","unstructured":"Mackie-Ramos RL, Rice JM (1988) Group psychotherapy with methadone-maintained pregnant women. J Subst Abuse Treat 5:151\u2013161","journal-title":"J Subst Abuse Treat"},{"key":"35_CR14","first-page":"399","volume":"71","author":"KC Edelin","year":"1988","unstructured":"Edelin KC, Gurganious L, Golar K, Oellerich D, Kyei-Aboagye K, Hamid M (1988) Methadone maintenance in pregnancy: consequences to care and outcome. Obsett Gynae 71:399\u2013404","journal-title":"Obsett Gynae"},{"key":"35_CR15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/15563658608992594","volume":"24","author":"C Offidani","year":"1986","unstructured":"Offidani C, Chiarotti M, De Giovanni N, Falasconi AM (1986) Methadone in pregnancy: clinical-toxicological aspects. J Tox Clin Toxicol 24:295\u2013303","journal-title":"J Tox Clin Toxicol"},{"key":"35_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1300\/J069v18n04_05","volume":"18","author":"MA Jarvis","year":"1999","unstructured":"Jarvis MA, Wu-Pong S, Kniseley JS, Schnoll SH (1999) Alterations in methadone metabolism during late pregnancy. J Addict Dis 18:51\u201361","journal-title":"J Addict Dis"},{"key":"35_CR17","volume-title":"Drug misuse and dependence-guidelines on clinical management","author":"Department of Health","year":"1999","unstructured":"Department of Health (1999) Drug Misuse and Dependence-Guidelines on Clinical Management. The Stationery Office, London, UK"},{"key":"35_CR18","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1046\/j.1360-0443.2000.951217717.x","volume":"95","author":"K Wolff","year":"2000","unstructured":"Wolff K, Rostami-Hodjegan A, Hay AW, Raistrick D, Tucker G (2000) Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility. Addiction 95:1771\u20131783","journal-title":"Addiction"},{"key":"35_CR19","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","volume":"41","author":"CB Eap","year":"2002","unstructured":"Eap CB, Buclin T, Baumann P (2002) Interindividual variability of the clinical pharmacokinetics of methadone, Implications for the treatment of opioid dependence. Clin Pharmacol 41:1153\u20131193","journal-title":"Clin Pharmacol"},{"key":"35_CR20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clpt.2004.05.003","volume":"76","author":"ED Kharasch","year":"2004","unstructured":"Kharasch ED, Hoffer C, Whittington D, Sheffels P (2004) Role of heptatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone. Cli Pharmacol & Therap 76:250\u2013269","journal-title":"Cli Pharmacol & Therap"},{"key":"35_CR21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0960-0760(00)00121-7","volume":"74","author":"DFV Lewis","year":"2000","unstructured":"Lewis DFV, Ioannides C, Parke DV, Schulte-Hermann R (2000) Quantitative structure activity relationships in a series of endogenous and synthetic steroids exhibiting induction of CYP3A activity and hepatomegaly associated with increased DNA synthesis. J Steroid Biochem Mol Biol 74:179\u2013185","journal-title":"J Steroid Biochem Mol Biol"},{"key":"35_CR22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ajog.2004.08.030","volume":"192","author":"TS Tracy","year":"2005","unstructured":"Tracy TS, Venkataramanan R, Glover DD, Caritis SN (2005) Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. Amer J Obstet Gynae 192:633\u2013639","journal-title":"Amer J Obstet Gynae"},{"key":"35_CR23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0009-9236(97)90118-1","volume":"62","author":"M Wadelius","year":"1997","unstructured":"Wadelius M, Darj E, Frenne G, Rane A (1997) Induction of CYP2D6 in pregnancy. J Clin Pharmacol Therap 62:400\u2013407","journal-title":"J Clin Pharmacol Therap"},{"key":"35_CR24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bcp.2004.09.008","volume":"69","author":"IA Nekhayeva","year":"2005","unstructured":"Nekhayeva IA, Nanovskaya TN, Deshmukh SV, Zharikova OL (2005) Bidirectional transfer of methadone across human placenta. Biochem Pharmacol 69:187\u2013197","journal-title":"Biochem Pharmacol"},{"key":"35_CR25","first-page":"10","volume":"15","author":"K Clarke","year":"2000","unstructured":"Clarke K, Formby J (2000) Feeling good, doing fine. Druglink 15:10\u201313","journal-title":"Druglink"},{"key":"35_CR26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/jama.1973.03220320013004","volume":"225","author":"G Blinick","year":"1973","unstructured":"Blinick G, Jerez E, Walach RC (1973) Methadone Maintenance, Pregnancy and progeny. JAMA 225:477\u2013479","journal-title":"JAMA"},{"key":"35_CR27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2125.1997.t01-1-00591.x","volume":"44","author":"K Wolff","year":"1997","unstructured":"Wolff K, Rostami-Hodjegan A, Shires S, Hay A W, Feely M, Calvert R, Raistrick D, Tucker G T (1997) The pharmacokinetics of methadone in healthy subjects and opiate users. Brit J Clin Pharm 44:325\u2013334","journal-title":"Brit J Clin Pharm"},{"key":"35_CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2125.1999.00974.x","volume":"48","author":"A Rostami-Hodjegan","year":"1999","unstructured":"Rostami-Hodjegan A, Wolff K, Hay AW, Raistrick D, Calvert R, Tucker GT (1999) Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes. Brit J Clin Pharmacol 48:43\u201452","journal-title":"Brit J Clin Pharmacol"},{"key":"35_CR29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0899-3289(20)30008-0","volume":"1","author":"RM Swift","year":"1989","unstructured":"Swift RM, Dudley M, DePetrillo P, Camara P, Griffiths W (1989) Altered methadone pharmacokinetics in pregnancy: implications for dosing. J Subst Abuse 1:453\u2013460","journal-title":"J Subst Abuse"},{"key":"35_CR30","doi-asserted-by":"crossref","first-page":"15068","DOI":"10.1021\/bi034409n","volume":"42","author":"N Torimoto","year":"2003","unstructured":"Torimoto N, Ishii I, Hata M, Nakamura H, Imada H, Ariyoshi N, Ohmori S, Igarashi T, Kitada M (2003) Direct interaction between substrates and endogenous steroids in the active site may change activity of Cytochrome P450 3A4. Biochem 42:15068\u201315077","journal-title":"Biochem"},{"issue":"1","key":"35_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/dmd.31.1.1","volume":"31","author":"M Sarkar","year":"2003","unstructured":"Sarkar M, Vadlamuri V, Ghosh S, Glover DD (2003) Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle. Drug Metabolism & Disposition 31(1):1\u20136","journal-title":"Drug Metab Dispos"},{"key":"35_CR32","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1124\/jpet.104.068908","volume":"311","author":"ET Williams","year":"2004","unstructured":"Williams ET, Leyk M, Wrighton SA, Davies PJ, Loose DS, Shipley GL, Strobel HW (2004) Estrogen regulation of the Cytochrome P450 3A subfamily in humans. J Pharmacol Exper Therap 311:728\u2013735","journal-title":"J Pharmacol Exper Therap"},{"key":"35_CR33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2165\/00003088-200241120-00003","volume":"41","author":"J Alcorn","year":"2002","unstructured":"Alcorn J, McNamara PJ (2002) Ontogeny of hepatic and renal systematic clearance pathways in infants. Clin Pharmacol 41:959\u2013998","journal-title":"Clin Pharmacol"},{"key":"35_CR34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bcp.2004.04.011","volume":"68","author":"TN Nanovskaya","year":"2004","unstructured":"Nanovskaya TN, Deshmukh SV, Nekhayeva IA, Zharikova OL Hankins GD, Ahmed MS (2004) Methadone metabolism in the human placenta. Biochem Pharmacol 68:583\u2013591","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"35_CR35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bbrc.2004.04.041","volume":"318","author":"T Matsunaga","year":"2004","unstructured":"Matsunaga T, Maruyama M, Harada E, Katsuyama Y, Sugihara N, Ise H, Negishi N, Ikeda U, Ohmori S (2004) Expression and induction of CYP3As in human fetal hepatocytes. Biochem Biophy Res Comm 318(2):428\u2013434","journal-title":"Biochem Biophy Res Comm"},{"key":"35_CR36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1124\/dmd.30.8.883","volume":"30","author":"JA Williams","year":"2002","unstructured":"Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, Hamman MA, Hall SD, Wrighton SA (2002) Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Disposition 30:883\u2013891","journal-title":"Drug Metab Disposition"},{"key":"35_CR37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0163-7258(99)00046-7","volume":"84","author":"JA Ring","year":"1999","unstructured":"Ring JA, Ghabrial H, Ching MS, Smallwood RA, Morgan DJ (1999) Fetal hepatic drug elimination. J Pharmacol Therap 84:429\u2013445","journal-title":"J Pharmacol Therap"},{"key":"35_CR38","first-page":"1367","volume-title":"Primary Pediatric Care 2nd edn","author":"LP Finnegan","year":"1992","unstructured":"Finnegan LP, Kaltenbach K (1992) Neonatal abstinence syndrome, In: Hoekeman RA, Friedman SB, Nelson N, Seidel HM (eds) Primary Pediatric Care 2nd edn, 1367\u20131378, St Louis, CV, Mosby, USA"},{"key":"35_CR39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/j.1875-9114.1993.tb02725.x","volume":"13","author":"M Levy","year":"1993","unstructured":"Levy M, Spino M (1993) Neonatal withdrawal syndrome: associated drugs and pharmacologic management, Pharmacotherapy 13:202\u2013211","journal-title":"Pharmacotherapy"},{"key":"35_CR40","first-page":"58","volume":"149","author":"SR Kandall","year":"1995","unstructured":"Kandall SR (1995) Treatment options for drug-exposed infants, NIDA Research Monograph 149:58\u201377","journal-title":"NIDA Res Monogr"},{"key":"35_CR41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/clpt.1981.34","volume":"29","author":"MK Romach","year":"1981","unstructured":"Romach MK, Piafsky KM, Abel JG, Khouw V, Sellers EM (1981) Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinat of free fraction in plasma. Clin Pharmacol Ther 29:211\u2013217","journal-title":"Clin Pharmacol Ther"},{"key":"35_CR42","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2165\/00003495-200161130-00003","volume":"61","author":"F Keller","year":"2001","unstructured":"Keller F, Griesshammer M, Haussler U, Paulus W, Schwarz A (2001) Pregnancy and renal failure: the case for application of dosage guidelines. Drugs 61:1901\u20131920","journal-title":"Drugs"},{"key":"35_CR43","first-page":"106","volume":"27","author":"JG Gerber","year":"2001","unstructured":"Gerber JG, Rosenkranz S, Segal Y, Aberg J, D'Amico R, Mildvan D, Gulick R, Hughes V, Flexner C, Aweeka F, Hsu A, Gal J, ACTG 401 Study Team (2001) Effect of ritonavir\/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401. J Immune Def Syndromes: JAIDS 27:106\u2013153","journal-title":"J Immune Def Syndromes: JAIDS"},{"key":"35_CR44","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2125.2004.02079.x","volume":"57","author":"DJ Foster","year":"2004","unstructured":"Foster DJ, Somogyi AA, White JM, Bochner F (2004) Population pharmacokinetics of R-, (S)- and rac-methadone in methadone maintenance patients. Br J Clin Pharmacol 57:742\u2013755","journal-title":"Br J Clin Pharmacol"},{"key":"35_CR45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mcp.2001.116793","volume":"70","author":"DW Boulton","year":"2001","unstructured":"Boulton DW, Arnaud P, Devane CL (2001) Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate. Clin Pharmacol Ther 70:48\u201357","journal-title":"Clin Pharmacol Ther"},{"key":"35_CR46","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/jps.20171","volume":"93","author":"M Rodrigo","year":"2004","unstructured":"Rodrigo M, Ortega I, Soengas I, Lean N, Saurez E, Calvo R, Lukas JC (2004) Alpha-1-acid glycoprotein directly effects the pharmacokinetics and the analgesic effect of methadone in the rat beyond protein binding. J of Pharm Sci 93:2836\u20132850","journal-title":"J of Pharm Sci"},{"key":"35_CR47","volume-title":"Challenging childbirth: good practice in maternity care. London, Department of Health","author":"Department of Health","year":"1993","unstructured":"Department of Health (1993) Challenging Childbirth: Good Practice in Maternity Care. London, Department of Health, The Stationery Office, London, UK"},{"key":"35_CR48","volume-title":"Drugs, pregnancy & childcare: a guide for professionals","author":"Standing Conference on Drug Abuse (SCODA), Local Government Drugs Forum","year":"1991","unstructured":"Standing Conference on Drug Abuse (SCODA), Local Government Drugs Forum (1997) Drug using parents: policy guidelines for inter-agency working. London: LGDF"},{"key":"35_CR49","volume-title":"Drugs, pregnancy & childcare: a guide for professionals","author":"J Mounteney","year":"1991","unstructured":"Mounteney J (1999) Drugs, pregnancy & childcare: a guide for professionals. London: ISDD, UK"},{"key":"35_CR50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bcp.2005.03.030","volume":"69","author":"TN Nanovskaya","year":"2005","unstructured":"Nanovskaya TN, Nekhayeva I, Karunaratne N, Audus K, Hankins GD, Ahmed MS (2005) Role of P-glycoprotein in transplacental transfer of methadone. Biochem Pharmacol 69:583\u2013591","journal-title":"Biochem Pharmacol"},{"key":"35_CR51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1472-8206.2003.00140.x","volume":"17","author":"BM Strolin","year":"2003","unstructured":"Strolin BM, Baltes EL (2003) Drug metabolism and disposition in children. Fund Clinl Pharmacol 17:281\u2013299","journal-title":"Fund Clinl Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0035-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-005-0035-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0035-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T09:51:47Z","timestamp":1706694707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-005-0035-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1007\/s00228-005-0035-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}